FDA Inspection 1280570 — Frontida BioPharm LLC
The FDA completed an inspection of Frontida BioPharm LLC on July 22, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Tobacco.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 22, 2025
- Fiscal Year
- 2025
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Philadelphia, PA (United States)